[Postoperative inflammation in cataract surgery with intraocular correction].
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D000925:Anticoagulants / Q000627:therapeutic use; D001672:Biocompatible Materials; D002387:Cataract Extraction / Q000009:adverse effects*; D048909:Diabetes Complications; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D005549:Foreign-Body Reaction / Q000209:etiology; D005901:Glaucoma / Q000150:complications; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D019654:Lens Implantation, Intraocular / Q000009:adverse effects*; D007910:Lenses, Intraocular / Q000009:adverse effects*; D010960:Plasminogen Activators / Q000627:therapeutic use; D011183:Postoperative Complications / Q000209:etiology / Q000276:immunology / Q000517:prevention & control; D011379:Prognosis; D012307:Risk Factors; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use
D000276:Adjuvants, Immunologic; D000894:Anti-Inflammatory Agents, Non-Steroidal; D000925:Anticoagulants; D001672:Biocompatible Materials; D005343:Fibrinolytic Agents; D006493:Heparin; D010960:Plasminogen Activators; D010959:Tissue Plasminogen Activator
Posleoperatsionnoe vospalenie v khirurgii katarakty s intraokuliarnoĭ korrektsieĭ.